cgp 54626 has been researched along with nisoxetine in 1 studies
| Studies (cgp 54626) | Trials (cgp 54626) | Recent Studies (post-2010) (cgp 54626) | Studies (nisoxetine) | Trials (nisoxetine) | Recent Studies (post-2010) (nisoxetine) |
|---|---|---|---|---|---|
| 57 | 0 | 16 | 316 | 2 | 62 |
| Protein | Taxonomy | cgp 54626 (IC50) | nisoxetine (IC50) |
|---|---|---|---|
| Cytochrome P450 1A1 | Homo sapiens (human) | 0.0079 | |
| Cytochrome P450 1A2 | Homo sapiens (human) | 0.0079 | |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 2.4 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.0131 | |
| Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | 0.0083 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.8628 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 1.65 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akaike, A; Katsuki, H | 1 |
1 other study(ies) available for cgp 54626 and nisoxetine
| Article | Year |
|---|---|
Quinolinic acid toxicity on orexin neurons blocked by gamma aminobutyric acid type A receptor stimulation.
Topics: Animals; Animals, Newborn; Bicuculline; Cell Count; Citalopram; Dose-Response Relationship, Drug; Drug Interactions; Fluoxetine; GABA Agonists; GABA Antagonists; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Hypothalamus; Immunohistochemistry; In Vitro Techniques; Intracellular Signaling Peptides and Proteins; Magnesium; Neurons; Neuropeptides; Nipecotic Acids; Norepinephrine; Orexin Receptors; Orexins; Organophosphorus Compounds; Picrotoxin; Quinolinic Acid; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Receptors, GABA-A; Receptors, Neuropeptide; Selective Serotonin Reuptake Inhibitors; Serotonin | 2005 |